February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla: Capturing Opportunity in a Contrarian Market
Microsoft: Resilient Amid Sell-Off, 'Buy' Stance Reaffirmed
3M: Valuation Challenges Amidst Limited Growth Prospects
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Conduit Pharmaceuticals Inc. (CDT) Stock Forecast for 2025, 2026, 2027. Cdt Prediction. Sell or Buy?
Updated: March 17, 2025 (02:35)
Sector: HealthcareThe share price of Conduit Pharmaceuticals Inc. (CDT) now
Are you interested in Conduit Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Conduit Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Conduit Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Conduit Pharmaceuticals stock? When should I record a loss on Conduit Pharmaceuticals stock? What are analysts' forecasts for Conduit Pharmaceuticals stock? What is the future of Conduit Pharmaceuticals stock? We forecast Conduit Pharmaceuticals stock performance using neural networks based on historical data on Conduit Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Conduit Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Conduit Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Conduit Pharmaceuticals stock
The chart below shows the historical price of Conduit Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Conduit Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Conduit Pharmaceuticals Inc. (CDT) is a clinical-stage biopharmaceutical company focused on advancing and commercializing clinical assets, particularly those overlooked by larger pharmaceutical firms. Their pipeline includes a glucokinase activator ready for Phase II trials, targeting autoimmune diseases, and a human Myeloperoxidase inhibitor for treating idiopathic male infertility.
Conduit utilizes strategic partnerships, such as collaborations with Agility Life Sciences and Sarborg, to enhance drug development and create innovative solutions. They also inaugurated a new lab in Cambridge to boost their intellectual property. Recent moves include debt restructuring and new financing arrangements to improve financial flexibility. A reverse stock split was enacted to meet Nasdaq’s minimum bid price.
While Conduit shows promise through innovative strategies and a robust pipeline, potential investors should carefully weigh the company’s financial challenges, including operating losses and debt.
Conduit Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar 18 | 1.21 | 0.98 | 1.27 | 30.03 |
| Mar 19 | 1.25 | 1.04 | 1.50 | 43.54 |
| Mar 20 | 1.39 | 1.15 | 1.61 | 40.30 |
| Mar 21 | 1.34 | 1.26 | 1.59 | 25.46 |
| Mar 22 | 1.64 | 1.47 | 1.91 | 29.44 |
| Mar 23 | 1.63 | 1.47 | 1.85 | 25.83 |
| Mar 24 | 1.45 | 1.35 | 1.66 | 23.06 |
| Mar 25 | 1.29 | 1.05 | 1.45 | 38.46 |
| Mar 26 | 1.47 | 1.25 | 1.69 | 35.10 |
| Mar 27 | 1.43 | 1.32 | 1.65 | 24.86 |
| Mar 28 | 1.53 | 1.31 | 1.64 | 24.71 |
| Mar 29 | 1.87 | 1.70 | 2.08 | 22.25 |
| Mar 30 | 1.71 | 1.48 | 2.05 | 38.33 |
| Mar 31 | 2.06 | 1.90 | 2.38 | 25.20 |
| Apr 01 | 2.19 | 1.77 | 2.50 | 41.61 |
| Apr 02 | 2.56 | 2.30 | 2.76 | 20.06 |
| Apr 03 | 2.98 | 2.52 | 3.29 | 30.38 |
| Apr 04 | 3.70 | 3.48 | 4.39 | 26.33 |
| Apr 05 | 3.74 | 3.03 | 4.38 | 44.75 |
| Apr 06 | 3.98 | 3.50 | 4.49 | 28.12 |
| Apr 07 | 3.76 | 3.04 | 4.21 | 38.70 |
| Apr 08 | 2.89 | 2.47 | 3.45 | 39.77 |
| Apr 09 | 2.95 | 2.43 | 3.30 | 35.87 |
| Apr 10 | 3.08 | 2.66 | 3.26 | 22.54 |
| Apr 11 | 2.71 | 2.49 | 2.90 | 16.62 |
| Apr 12 | 2.84 | 2.42 | 3.01 | 24.05 |
| Apr 13 | 2.74 | 2.32 | 3.09 | 33.04 |
| Apr 14 | 2.78 | 2.51 | 2.94 | 17.45 |
| Apr 15 | 2.94 | 2.48 | 3.43 | 38.28 |
| Apr 16 | 2.37 | 2.12 | 2.51 | 18.16 |
Conduit Pharmaceuticals Daily Price Targets
Conduit Pharmaceuticals Stock Forecast 03-18-2025.
Forecast target price for 03-18-2025: $1.21.
Positive dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 23.095%.
Pessimistic target level: 0.98
Optimistic target level: 1.27
Conduit Pharmaceuticals Stock Forecast 03-19-2025.
Forecast target price for 03-19-2025: $1.25.
Positive dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 30.335%.
Pessimistic target level: 1.04
Optimistic target level: 1.50
Conduit Pharmaceuticals Stock Forecast 03-20-2025.
Forecast target price for 03-20-2025: $1.39.
Positive dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 28.726%.
Pessimistic target level: 1.15
Optimistic target level: 1.61
Conduit Pharmaceuticals Stock Forecast 03-21-2025.
Forecast target price for 03-21-2025: $1.34.
Negative dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 20.296%.
Pessimistic target level: 1.26
Optimistic target level: 1.59
Conduit Pharmaceuticals Stock Forecast 03-22-2025.
Forecast target price for 03-22-2025: $1.64.
Positive dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 22.747%.
Pessimistic target level: 1.47
Optimistic target level: 1.91
Conduit Pharmaceuticals Stock Forecast 03-23-2025.
Forecast target price for 03-23-2025: $1.63.
Negative dynamics for Conduit Pharmaceuticals shares will prevail with possible volatility of 20.530%.
Pessimistic target level: 1.47
Optimistic target level: 1.85
CDT (CDT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr. | 1.43 | 1.22 | 1.79 | 31.76 |
| May. | 1.55 | 1.41 | 1.75 | 19.35 |
| Jun. | 1.76 | 1.60 | 2.14 | 25.27 |
| Jul. | 2.03 | 1.54 | 2.47 | 37.50 |
| Aug. | 1.74 | 1.62 | 2.04 | 20.50 |
| Sep. | 1.58 | 1.34 | 1.80 | 25.93 |
| Oct. | 1.46 | 1.14 | 1.73 | 34.35 |
| Nov. | 1.47 | 1.14 | 1.59 | 28.44 |
| Dec. | 1.37 | 1.25 | 1.66 | 24.86 |
Conduit Pharmaceuticals forecast for this year
Conduit Pharmaceuticals Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $1.42572. Pessimistic: $1.22. Optimistic: $1.79
Conduit Pharmaceuticals Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $1.55275. Pessimistic: $1.41. Optimistic: $1.75
Conduit Pharmaceuticals Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $1.76284. Pessimistic: $1.60. Optimistic: $2.14
Conduit Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $2.03044. Pessimistic: $1.54. Optimistic: $2.47
Conduit Pharmaceuticals Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $1.73562. Pessimistic: $1.62. Optimistic: $2.04
Conduit Pharmaceuticals Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $1.57525. Pessimistic: $1.34. Optimistic: $1.80
Conduit Pharmaceuticals Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $1.45569. Pessimistic: $1.14. Optimistic: $1.73
Conduit Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $1.4701. Pessimistic: $1.14. Optimistic: $1.59
Conduit Pharmaceuticals Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.37307. Pessimistic: $1.25. Optimistic: $1.66
Conduit Pharmaceuticals (CDT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.76 | 1.31 | 2.17 | 39.84 |
| Feb | 1.27 | 0.94 | 1.55 | 39.08 |
| Mar | 1.11 | 0.85 | 1.20 | 29.27 |
| Apr | 1.31 | 1.06 | 1.46 | 27.59 |
| May | 1.22 | 0.99 | 1.46 | 31.85 |
| Jun | 1.46 | 1.21 | 1.82 | 33.51 |
| Jul | 1.92 | 1.56 | 2.21 | 29.51 |
| Aug | 1.75 | 1.30 | 2.20 | 40.94 |
| Sep | 1.61 | 1.21 | 1.89 | 35.95 |
| Oct | 2.03 | 1.78 | 2.48 | 28.30 |
| Nov | 2.33 | 1.81 | 2.50 | 27.69 |
| Dec | 1.82 | 1.34 | 2.11 | 36.18 |
Conduit Pharmaceuticals (CDT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.02 | 1.88 | 2.50 | 24.86 |
| Feb | 1.41 | 1.11 | 1.77 | 37.03 |
| Mar | 1.68 | 1.44 | 1.99 | 27.57 |
| Apr | 2.12 | 1.86 | 2.61 | 28.68 |
| May | 2.49 | 2.12 | 2.80 | 24.34 |
| Jun | 2.95 | 2.71 | 3.15 | 14.20 |
| Jul | 2.70 | 2.51 | 3.20 | 21.66 |
| Aug | 2.20 | 1.89 | 2.35 | 19.44 |
| Sep | 1.88 | 1.72 | 2.00 | 13.93 |
| Oct | 1.87 | 1.42 | 2.23 | 36.18 |
| Nov | 1.98 | 1.81 | 2.33 | 22.47 |
| Dec | 1.69 | 1.54 | 1.86 | 16.82 |
Conduit Pharmaceuticals information and performance
4995 MURPHY CANYON ROAD, SUITE 300, SAN DIEGO, CA, UNITED STATES
Market capitalization of the Conduit Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CDT shares in the company outstanding by the market price of one share.
EBITDA of Conduit Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Conduit Pharmaceuticals Stock)
Should I Buy Conduit Pharmaceuticals Shares in 2025 year?
Does Conduit Pharmaceuticals pay dividends?
Which economic sector do Conduit Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Conduit Pharmaceuticals's shares?
